CLINICAL_TRIALS trial_result · 2026-04-13

Clinical Trial Update: A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 4]

Phase 4 study of TAK-503 in children and adolescents with ADHD has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Shire | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED | Results posted: 2026-04-13